Tenet Healthcare: Technological Upgrade for More Complex Medical Procedures Drives EBITDA Margin Above 23%!
Reading Time: 3 minutes
Q2 Report: Increased case severity and the growth in outpatient surgery centers (USPI) drive EBITDA margin to 23.2%. Outlook: Tenet revises its annual forecast upward and increases the share buyback program by an additional $2 billion. Strategy: One-time effects from Conifer and the targeted focus on highly complex treatments ensure long-term profitability. More Complex Procedures Proven to Drive Profitability Tenet HealthCare (THC) has transformed in recent years from a traditional hospital-focused operator to a highly diversified healthcare...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
